Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about NanoViricides

Recent news which mentions NanoViricides

A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?

January 31, 2024

NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024

January 08, 2024

As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?

December 18, 2023

Is This Ticker That InvestorObservers Expects To Soar By More Than 350% Next Year On Your Watchlist?

November 30, 2023

NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387

November 29, 2023

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant

October 02, 2023

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant

September 26, 2023

First Human Clinical Trials Of A Potentially "Game-Changing Broad Spectrum Antiviral" Are Progressing Successfully – Drug Could Treat COVID, RSV And Many Other Respiratory Viruses

September 18, 2023

NanoViricides progressing well with new Covid study

August 31, 2023

SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?

July 18, 2023

NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst

July 13, 2023

NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment

July 05, 2023

NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2

June 29, 2023

This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?

April 19, 2023

NanoViricides using unique technology platform to fight against viruses

April 12, 2023

COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All

March 31, 2023

A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats

March 20, 2023

With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Lik

March 08, 2023

This Company Is Looking For A Monkeypox Drug As City Investigates Deaths

October 27, 2022

European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy

August 26, 2022

European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy

August 26, 2022

Omicron BA.4/5 Subvariants Are More Contagious And More Treatment-Resistant, But This Biopharma Reports Working On A Potential Breakthrough

August 03, 2022

NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants

May 25, 2022

NanoViricides Begins Drug Development Against Severe Pediatric Hepatitis; Expects To Be Successful In Short Period If Existing Candidates In Drug Library Prove Effective

May 18, 2022

NanoViricides Reports That It Has Begun Drug Development To Combat Recent Cases Of Severe Pediatric Hepatitis

May 16, 2022

Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach

February 28, 2022

Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts

January 19, 2022

NanoViricides Says Data Shows Its New Antiviral Could Fight all COVID-19 Variants

December 22, 2021

NanoViricides Attempts to Leverage Decades of Combined Pharmaceutical and Biotech Experience To Bring Broad-Spectrum COVID-19 Antiviral to Market

December 20, 2021

NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants

December 09, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.